Bottom line
How much do PRHSX and HGHAX overlap?
65% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 52.1% of PRHSX's assets and 53.7% of HGHAX's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 80), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and HGHAX have in common
| Holding | % of PRHSX | % of HGHAX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 12.03% | 12.03% |
| Johnson & Johnson | 6.63% | 6.75% | 6.63% |
| Unitedhealth Group Inc | 5.99% | 4.74% | 4.74% |
| Abbvie Inc | 5.10% | 4.21% | 4.21% |
| Merck & Co. Inc. | 4.01% | 6.00% | 4.01% |
| Thermo Fisher Scientific Inc | 2.52% | 1.58% | 1.58% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.64% | 2.28% |
| Abbott Laboratories | 1.89% | 1.82% | 1.82% |
| Intuitive Surgical Inc | 1.87% | 2.88% | 1.87% |
| Amgen Inc | 1.82% | 1.39% | 1.39% |
| Stryker Corp | 1.78% | 1.24% | 1.24% |
| Elevance Health Inc | 1.53% | 3.00% | 1.53% |
| Danaher Corp | 1.43% | 2.57% | 1.43% |
| Cvs Health Corp | 0.94% | 2.84% | 0.94% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Gilead Sciences Inc — 2.82%
- Bristol-myers Squibb Co — 2.11%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Only in HGHAX
- Edwards Lifesciences Corp — 2.48%
- Cencora Inc — 2.46%
- Regeneron Pharmaceuticals Inc — 2.02%
- HCA Healthcare Inc — 1.88%
- Boston Scientific Corp — 1.88%
- Agilent Technologies Inc — 1.54%
- Biogen Inc — 1.36%
- Gsk Plc — 1.17%
- Medtronic PLC — 1.12%
- Centene Corp — 1.10%
- Dexcom Inc — 1.01%
Asset mix
| Asset type | PRHSX | HGHAX |
|---|---|---|
| Stocks | 96.4% | 98.1% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 0.7% | 0.9% |
| Repurchase agreements | — | 0.4% |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | PRHSX | HGHAX |
|---|---|---|
| US | 92.6% | 89.6% |
| GB | 1.7% | 2.4% |
| IE | 0.8% | 2.2% |
| NL | 1.0% | 1.5% |
| BE | — | 0.8% |
| DK | 0.7% | 0.8% |
| BM | 0.7% | — |
| CH | 0.5% | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PRHSX and HGHAX overlap?
What stocks do PRHSX and HGHAX have in common?
Should I own both PRHSX and HGHAX?
Which holds more stocks, PRHSX or HGHAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.